Physician profile

Peter Chang

Urology · Boston, MA

NPI 1275733867

$18,485.68

in general payments reported to CMS, 2019-2025

9 companies · none reported in 2025

Payments by year

General payments by program year, as reported to CMS.

What the payments were for

Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.

View as a table
Payment typeAmount (2023-2025)
Education$12,000.00
Travel and Lodging$1,410.39
Food and Beverage$1,053.14

Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.

Who reported paying

General payments only, as reported to CMS. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
Intuitive Surgical, INC. $17,647.68 2022-2024 Da Vinci Surgical System
Urogen Pharma, INC. $178.69 2024
Alimera Sciences, INC. $166.92 2019
Dutch Ophthalmic, USA $152.70 2023-2024 Tissueblue, Eva, Combined Machine
Astellas Pharma US INC $150.99 2022-2024 Xtandi
Abbvie INC. $127.22 2022
Sun Pharmaceutical Industries INC. $32.07 2022
Edap Technomed INC $15.00 2024
Metuchen Pharmaceuticals $14.41 2020

Drugs and devices associated with these payments

CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

Peter Chang

$18,485.68

in general payments reported 2019-2025

Years
2019-2024
Top company
Intuitive Surgical, INC.

https://glasscript.com/doctor/102788/peter-chang

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Watch this doctor

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.